Susan Dent Joins DCI to Co-lead Cardio-Oncology
Susan Dent, MD, FRCPC, joined Duke Cancer Institute in September 2018 to co-lead Duke’s efforts in cardio-oncology—a discipline focused on the intersection of heart disease and cancer.
She will also serve as professor of medicine and associate director of breast cancer clinical research.
Before joining the Duke faculty, Dent was a medical oncologist at the Ottawa Hospital Cancer Centre and professor in the Department of Medicine at the University of Ottawa. Her areas of interest include breast cancer, treatment toxicities, and cardiotoxicity.
She is the founder of the Ottawa Cardiac Oncology Program as well as the Canadian Cardiac Oncology Network, organizations dedicated to improving our understanding of how cancer treatments impact cardiovascular health with the ultimate goal of preventing cardiotoxicity.
This article appeared in the Fall 2018 issue of Breakthroughs, a magazine produced twice yearly by Duke Cancer Institute Office of Development. Subscribe to Breakthroughs.